Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Outbreak of GES-1 beta-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal
A Duarte, F Boavida, F Grosso, et al.
Communications in Agricultural and Applied Biological Sciences
|
August 22, 2014
Microencapsulated diets for altricial freshwater fish larvae: production and evaluation
N J Leitão, J B Rodrigues, C R F Grosso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2010
Tumor response to sunitinib malate observed in clear-cell sarcoma
S Stacchiotti, F Grosso, T Negri, et al.
The British Journal of Dermatology
|
May 18, 2011
A founder synonymous COL7A1 mutation in three Danish families with dominant dystrophic epidermolysis bullosa pruriginosa identifies exonic regulatory sequences required for exon 87 splicing
C Covaciu, F Grosso, E Pisaneschi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 2003
Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor
Jennifer L Owen, Vijaya Iragavarapu-Charyulu, Zeenat Gunja-Smith, et al.
The British Journal of Dermatology
|
November 16, 2004
Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients
F Mariotti, F Grosso, M Terracina, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2006
Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma
F Grosso, P Dileo, R Sanfilippo, et al.
Cellular Immunology
|
October 26, 2005
The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors
Jennifer L Owen, Diana M Lopez, Joseph F Grosso, et al.
British Journal of Cancer
|
July 26, 2012
Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies
M Mandalà, F Grosso, C Vitalini, et al.
Cancer Research
|
November 3, 2004
A unique mucin immunoenhancing peptide with antitumor properties
Lynn M Herbert, Joseph F Grosso, Mantley Dorsey, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
Antimicrobial Agents and Chemotherapy
|
March 26, 2003
Outbreak of GES-1 beta-lactamase-producing multidrug-resistant Klebsiella pneumoniae in a university hospital in Lisbon, Portugal
A Duarte, F Boavida, F Grosso, et al.
Communications in Agricultural and Applied Biological Sciences
|
August 22, 2014
Microencapsulated diets for altricial freshwater fish larvae: production and evaluation
N J Leitão, J B Rodrigues, C R F Grosso, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2010
Tumor response to sunitinib malate observed in clear-cell sarcoma
S Stacchiotti, F Grosso, T Negri, et al.
The British Journal of Dermatology
|
May 18, 2011
A founder synonymous COL7A1 mutation in three Danish families with dominant dystrophic epidermolysis bullosa pruriginosa identifies exonic regulatory sequences required for exon 87 splicing
C Covaciu, F Grosso, E Pisaneschi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 8, 2003
Up-regulation of matrix metalloproteinase-9 in T lymphocytes of mammary tumor bearers: role of vascular endothelial growth factor
Jennifer L Owen, Vijaya Iragavarapu-Charyulu, Zeenat Gunja-Smith, et al.
The British Journal of Dermatology
|
November 16, 2004
Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients
F Mariotti, F Grosso, M Terracina, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 2, 2006
Steroid premedication markedly reduces liver and bone marrow toxicity of trabectedin in advanced sarcoma
F Grosso, P Dileo, R Sanfilippo, et al.
Cellular Immunology
|
October 26, 2005
The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors
Jennifer L Owen, Diana M Lopez, Joseph F Grosso, et al.
British Journal of Cancer
|
July 26, 2012
Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies
M Mandalà, F Grosso, C Vitalini, et al.
Cancer Research
|
November 3, 2004
A unique mucin immunoenhancing peptide with antitumor properties
Lynn M Herbert, Joseph F Grosso, Mantley Dorsey, et al.
Page
of 10